Complications associated with fluid extravasation during shoulder arthroscopy
Conditions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients scheduled for arthroscopic shoulder surgery; 2. Patients aged 18-60 years, ASA grade I-II, regardless of gender; 3. Patients with 18kg / m2 <= BMI <= 30kg / m2; 4. Patients with normal cognitive function; 5. Those patients who fully understand the trial and sign the informed consent.
Exclusion criteria
Exclusion criteria: 1. Patients with neck and chest anatomical structure variation or change; 2. Patients who are allergic to the components or components of thiazide diuretics, methylprednisolone, ulinastatin and ropivacaine that may be used in the study; 4. Patients with uncontrolled hypertension and diabetes mellitus (systolic blood pressure >= 160mmhg, or diastolic blood pressure >= 100mmhg, blood glucose >= 15mmol / L); 5. Patients with sleep apnea syndrome and epilepsy before operation; 6. Pregnant or breast-feeding patients with previous history of abuse of psychotropic drugs and narcotic drugs; 7. Patients unable to receive brachial plexus block (skin infection, brachial plexus injury); 8. Patients with severe liver and kidney diseases, pulmonary hypertension, heart failure (NYHA > II), coronary heart disease, myocardial infarction or shunt heart disease; 9. Patients with abnormal coagulation function; 10. Patients who are not suitable to participate in the clinical trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Edema in adjacent soft tissue; | — |
Countries
China
Contacts
Sichuan Provincial Orthopedic Hospital